Literature DB >> 19558760

Clostridium difficile: how much do hospital staff know about it?

Somaiah Aroori1, Natalie Blencowe, Geoff Pye, Reuben West.   

Abstract

INTRODUCTION: The aim of this study was to determine the awareness of Clostridium difficile infection amongst healthcare professionals. SUBJECTS AND METHODS: A total of 132 healthcare professionals (18 consultants, 40 trainee doctors, and 74 nursing staff) in our hospital were randomly surveyed using a questionnaire consisting of 17 questions covering various aspects of C. difficile.
RESULTS: More than 50% of healthcare professionals correctly identified C. difficile as an anaerobic bacillus. Half of the consultants and one-third of the trainees and nurses were aware that 5% of adults carry C. difficile in the gut. Overall, 80% of doctors and 40% of nursing staff (P = 0.001) were aware of the spectrum of illnesses caused by C. difficile. Seven (39%) consultants, 25 (63%) trainees, and 26 (37%) nurses correctly identified the various predisposing factors for the acquisition of C. difficile infection. Only one-third of doctors and 8% of nursing staff were aware that antibiotic restriction was the single most effective C. difficile infection control measure. In addition, 40% of doctors and 8% of nursing staff were aware that cytotoxin assay is the gold standard diagnostic test. Less than 30% of healthcare professionals were aware of the differences between the most common strain and the strain of C. difficile responsible for recent outbreaks. Only 6 (33%) consultants, 21 (53%) trainees (P = not significant), and 28 (38%) nursing staff were aware that hand washing with soap and water is the most effective way of preventing transmission of C. difficile infection. Results showed that 93% of trainees, 78% of consultants (P = 0.05) and 70% of nurses correctly answered that oral metronidazole is the drug of choice for the treatment of C. difficile infection. Compared to 73% of trainees, only two (11%) consultants (P < 0.0001) and 20 (27%) nursing staff correctly stated that oral vancomycin is the second-line treatment for persistent symptomatic C. difficile infection.
CONCLUSIONS: There is a significant lack of knowledge concerning C. difficile infection amongst healthcare professions, in particular amongst consultants and nurses in our hospital.

Entities:  

Mesh:

Year:  2009        PMID: 19558760      PMCID: PMC2966196          DOI: 10.1308/003588409X432310

Source DB:  PubMed          Journal:  Ann R Coll Surg Engl        ISSN: 0035-8843            Impact factor:   1.891


  17 in total

Review 1.  Compliance with hand disinfection and its impact on hospital-acquired infections.

Authors:  D Pittet
Journal:  J Hosp Infect       Date:  2001-08       Impact factor: 3.926

2.  Clostridium difficile infection in hospitals: risk factors and responses.

Authors:  Thomas J Louie; Jon Meddings
Journal:  CMAJ       Date:  2004-07-06       Impact factor: 8.262

3.  Clostridium difficile: a formidable foe.

Authors:  Vivian G Loo; Michael D Libman; Mark A Miller; Anne-Marie Bourgault; Charles H Frenette; Mirabelle Kelly; Sophie Michaud; Tuyen Nguyen; Louise Poirier; Anne Vibien; Ruth Horn; Pierre J Laflamme; Pierre René
Journal:  CMAJ       Date:  2004-07-06       Impact factor: 8.262

4.  The effect of an enhanced infection-control policy on the incidence of Clostridium difficile infection and methicillin-resistant Staphyloccocus aureus colonization in acute elderly medical patients.

Authors:  S P Stone; V Beric; A Quick; A A Balestrini; C C Kibbler
Journal:  Age Ageing       Date:  1998-09       Impact factor: 10.668

Review 5.  Guidelines for the diagnosis and management of Clostridium difficile-associated diarrhea and colitis. American College of Gastroenterology, Practice Parameters Committee.

Authors:  R Fekety
Journal:  Am J Gastroenterol       Date:  1997-05       Impact factor: 10.864

Review 6.  Clostridium difficile colitis.

Authors:  C P Kelly; C Pothoulakis; J T LaMont
Journal:  N Engl J Med       Date:  1994-01-27       Impact factor: 91.245

7.  Clostridium difficile-associated diarrhea in a region of Quebec from 1991 to 2003: a changing pattern of disease severity.

Authors:  Jacques Pépin; Louis Valiquette; Marie-Eve Alary; Philippe Villemure; Annick Pelletier; Karine Forget; Karine Pépin; Daniel Chouinard
Journal:  CMAJ       Date:  2004-08-31       Impact factor: 8.262

Review 8.  Review of Clostridium difficile-associated diseases.

Authors:  L V McFarland; W E Stamm
Journal:  Am J Infect Control       Date:  1986-06       Impact factor: 2.918

9.  Risk factors for Clostridium difficile infection.

Authors:  G E Bignardi
Journal:  J Hosp Infect       Date:  1998-09       Impact factor: 3.926

10.  Reduction of Clostridium Difficile and vancomycin-resistant Enterococcus contamination of environmental surfaces after an intervention to improve cleaning methods.

Authors:  Brittany C Eckstein; Daniel A Adams; Elizabeth C Eckstein; Agam Rao; Ajay K Sethi; Gopala K Yadavalli; Curtis J Donskey
Journal:  BMC Infect Dis       Date:  2007-06-21       Impact factor: 3.090

View more
  4 in total

Review 1.  Review of medical and surgical management of Clostridium difficile infection.

Authors:  B Faris; A Blackmore; N Haboubi
Journal:  Tech Coloproctol       Date:  2010-05-08       Impact factor: 3.781

Review 2.  Dentists, antibiotics and Clostridium difficile-associated disease.

Authors:  N Beacher; M P Sweeney; J Bagg
Journal:  Br Dent J       Date:  2015-09-25       Impact factor: 1.626

3.  Lack of adherence to SHEA-IDSA treatment guidelines for Clostridium difficile infection is associated with increased mortality.

Authors:  I Patel; M Wungjiranirun; T Theethira; J Villafuerte-Galvez; N Castillo; M Akbari; C D Alonso; D A Leffler; C P Kelly
Journal:  J Antimicrob Chemother       Date:  2016-11-14       Impact factor: 5.790

4.  Microbiology Education in Nursing Practice.

Authors:  Robert J Durrant; Alexa K Doig; Rebecca L Buxton; JoAnn P Fenn
Journal:  J Microbiol Biol Educ       Date:  2017-09-01
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.